EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis
Authors
Keywords
-
Journal
MYCOSES
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-27
DOI
10.1111/myc.12820
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Isavuconazole shortens the QTc interval
- (2018) Sibylle C. Mellinghoff et al. MYCOSES
- Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
- (2018) John R. Perfect et al. MYCOSES
- Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species
- (2018) Francisco M. Marty et al. MYCOSES
- Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis
- (2017) J. J. Vehreschild et al. EUROPEAN RADIOLOGY
- Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study
- (2017) Philipp Koehler et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi
- (2017) Matthew W McCarthy et al. JOURNAL OF INFECTIOUS DISEASES
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Contemporary Strategies in the Prevention and Management of Fungal Infections
- (2016) Philipp Koehler et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis
- (2016) Lena M. Biehl et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2016) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- 1,3-β-d-Glucan contamination of common antimicrobials: Table 1.
- (2015) B. Liss et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 1,3-ß-D-glucan concentrations in blood products predict false positive post-transfusion results
- (2015) B. Liss et al. MYCOSES
- Our 2015 approach to invasive pulmonary aspergillosis
- (2015) B. Liss et al. MYCOSES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now